EGFR and adenocarcinoma: To test whether EGFR mutation status affects the prognostic potential of CEAIn and CEAPd in predicting PPS, adenocarcinoma patients were stratified into EGFR wild-type (n = 94) and EGFR-mutant (n = 194) groups and subjected to multivariable Cox model.